0002114097-26-000001.txt : 20260413 0002114097-26-000001.hdr.sgml : 20260413 20260413122000 ACCESSION NUMBER: 0002114097-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260413 DATE AS OF CHANGE: 20260413 EFFECTIVENESS DATE: 20260413 FILER: COMPANY DATA: COMPANY CONFORMED NAME: REVO Oncology Diagnostics Inc. CENTRAL INDEX KEY: 0002114097 ORGANIZATION NAME: EIN: 393792232 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-580105 FILM NUMBER: 26857077 BUSINESS ADDRESS: STREET 1: 2829 SPANISH MOSS TRAIL CITY: FRISCO STATE: TX ZIP: 75033 BUSINESS PHONE: 945-289-8305 MAIL ADDRESS: STREET 1: 2829 SPANISH MOSS TRAIL CITY: FRISCO STATE: TX ZIP: 75033 D 1 primary_doc.xml X0708 D LIVE 0002114097 REVO Oncology Diagnostics Inc. 2829 SPANISH MOSS TRAIL FRISCO TX TEXAS 75033 945-289-8305 DELAWARE REVO Oncology Inc. None Corporation true 2025 Estevan Kiernan c/o REVO Oncology Diagnostics Inc. 2829 Spanish Moss Trail Frisco TX TEXAS 75033 Executive Officer Director Other Health Care Decline to Disclose 06b false 2025-09-17 false true Simple Agreement for Future Equity false 0 1200000 270000 930000 false 7 0 0 0 Other than the payment of salaries and other compensation and benefits and reimbursement of expenses, no officer, director, partner, manager or promoter will receive and payments from the proceeds of this Offering. false REVO Oncology Diagnostics Inc. /s/ Estevan Kiernan Estevan Kiernan President and Chief Executive Officer 2026-04-13